EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Asprosin as a Potential Link Between Vascular Inflammation and Disease Activity in Behçet's Disease

Zeynep Kaya iD, Mesude Seda Aydogdu, Cihat Ucar, Mehmet Nur Kaya iD, Sezgin Zontul, Elif Inanc, Servet Yolbas

Journal of Clinical Laboratory Analysis · 2026

DOI: 10.1002/jcla.70216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2026. Verfasst von Zeynep Kaya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Istanbul Training and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Behcet Syndrome, Fibrillin-1, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Behçet's disease (BD) is a chronic multisystem vasculitis characterized by endothelial dysfunction and vascular inflammation. Asprosin is a recently identified adipokine implicated in endothelial injury and proinflammatory signaling. This study aimed to investigate serum asprosin concentrations in patients with BD and their relationship with disease activity and major clinical manifestations.

Methods

This cross‐sectional case–control study enrolled 49 patients who fulfilled the International Criteria for Behçet's Disease and 48 healthy controls. Disease activity was stratified as mild, moderate, or severe based on organ involvement using Yosipovitch's Behçet's Disease Classification. Serum asprosin levels were quantified using an enzyme‐linked immunosorbent assay. Associations among asprosin levels, disease activity, clinical manifestations, and inflammatory markers were analyzed.

Results

Serum asprosin concentrations were markedly elevated in individuals with Behçet's disease relative to healthy controls [12.18 (8.27–16.76) vs. 6.12 (4.76–8.61) ng/mL, p < 0.001] and increased incrementally as disease activity intensified ( p < 0.001). Patients with vascular involvement and uveitis demonstrated markedly elevated asprosin levels compared to patients without these manifestations ( p < 0.01). Correlation analysis revealed a strong positive association between serum asprosin levels and disease activity ( r = 0.821, p < 0.001), and a moderate correlation with C‐reactive protein (CRP) levels ( r = 0.431, p = 0.002). In multivariate analysis, both disease activity and CRP levels were independently associated with serum asprosin concentrations.

Conclusion

Serum asprosin levels are elevated in BD and closely associated with disease activity, systemic inflammation, and major organ involvement, particularly vascular manifestations and uveitis. Asprosin may represent a potential biomarker of the inflammatory and vascular burden in BD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Behcet SyndromeFibrillin-1InflammationHumansFemaleMaleCase-Control StudiesAdultCross-Sectional StudiesBiomarkersFibrillinsMiddle AgedAdipokines

Stichwörter der Autor:innen

Behçet's diseaseasprosindisease activityuveitisvascular inflammation

Substanzen

Fibrillin-1FBN1 protein, humanBiomarkersFibrillinsAdipokines

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Istanbul Training and Research Hospital, Istanbul, Turkey.
  • Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Malatya Turgut Ozal University, Malatya, Turkey.
  • Department of Physiology, Faculty of Medicine, Malatya Turgut Ozal University, Malatya, Turkey.
  • Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Balikesir University, Balikesir, Turkey.
  • Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Inonu University, Malatya, Turkey.
  • Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Inonu University, Malatya, Turkey.

ORCID-Profile: Zeynep Kaya, Mehmet Nur Kaya

Zitieren

APA

Kaya, Z., Aydogdu, M. S., Ucar, C., Kaya, M. N., Zontul, S., Inanc, E., & Yolbas, S. (2026). Asprosin as a Potential Link Between Vascular Inflammation and Disease Activity in Behçet's Disease. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70216

Vancouver

Kaya Z, Aydogdu MS, Ucar C, Kaya MN, Zontul S, Inanc E, et al. Asprosin as a Potential Link Between Vascular Inflammation and Disease Activity in Behçet's Disease. Journal of Clinical Laboratory Analysis. 2026. doi:10.1002/jcla.70216

BibTeX
@article{Kaya2026,
  author = {Kaya, Zeynep and Aydogdu, Mesude Seda and Ucar, Cihat and Kaya, Mehmet Nur and Zontul, Sezgin and Inanc, Elif and Yolbas, Servet},
  title = {Asprosin as a Potential Link Between Vascular Inflammation and Disease Activity in Behçet's Disease},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2026},
  doi = {10.1002/jcla.70216}
}
Kostenlos starten →